Vericel Corp (VCEL)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

64 SIDNEY ST. CAMBRIDGE, MA 02139

Aastrom Bioscience focuses on the development of processes and products for ex vivo production; and also on the sale of human cell products for use in cell therapy and regenerative medicine. Operated as a development stage company as of August 2005.

Data as of 2020-05-30
Market Cap648.691 Million Shares Outstanding45.111 Million Avg 30-day Volume796.215 Thousand
P/E Ratio Dividend Yield EPS-0.26
Price/Sales5.286 Price cash flow ratio Price free cash flow ratio-111.6
Book Value2.45 Price to Tangible Book5.81 Alpha0.04
Short Interest Ratio % Short Interest to Float R-squared0.154159
BETA2.92356 52-week High/Low19.95 / 6.78 Stddev0.318315
View SEC Filings from VCEL instead.

View recent insider trading info

Funds Holding VCEL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VCEL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

23.6 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GILMAN STEVEN C

  • Director
0 2020-05-12 1

COLANGELO DOMINICK PRESIDENT AND CEO

210,492 2020-05-08 6

RUBINO ALAN L

2,684 2020-04-29 1

ZERBE ROBERT L MD

19,295 2020-04-29 1

HAGEN HEIDI

1,750 2020-04-29 1

MCLAUGHLIN KEVIN F

1,750 2020-04-29 1

WOTTON PAUL K

1,750 2020-04-29 1

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
65,863 2020-04-24 0

MICHEL GERARD J CFO AND VP, CORP. DEVELOPMENT

253,865 2020-04-01 7

MAYLEBEN TIMOTHY M PRESIDENT & CEO

  • Officer
  • Director
111,998 2020-03-11 0

DUNBAR GEORGE W JR

  • Director
0 2020-02-12 0

HALPIN MICHAEL CHIEF OPERATING OFFICER

0 2020-02-11 4

HOPPER JONATHAN MARK CHIEF MEDICAL OFFICER

2,426 2020-02-11 2

FLYNN SEAN C. VP, GENERAL COUNSEL

0 2020-02-11 1

ORLANDO DANIEL CHIEF OPERATING OFFICER

59,960 2019-12-31 1

DURBIN SCOTT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-11-26 0

CONSONANCE CAPITAL MANAGEMENT LP

CONSONANCE CAPMAN GP, LLC

BLUTT MITCHELL J MD

  • 10% Owner
No longer subject to file 2016-03-28 0

SIMS NELSON M

  • Director
0 2015-03-20 0

ELLISTON MICHAEL W. CONTROLLER

  • Officer
0 2014-01-03 0

CRESSWELL RONALD M

  • Director
0 2013-05-02 0

URSCHEL HAROLD C JR

  • Director
0 2012-10-23 0

BARTEL RONNDA CHIEF SCIENTIFIC OFFICER

  • Officer
0 2012-06-25 0

WATLING SHARON VP CLINICAL DEVELOPMENT

  • Officer
0 2012-06-25 0

GIBSON BRIAN VICE PRESIDENT

  • Officer
0 2012-05-03 0

SUDOVAR STEPHEN

  • Director
0 2009-05-22 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

COLANGELO DOMINICK PRESIDENT AND CEO

2020-05-08 M 13,125 d 65,625 210,492.00 direct

COLANGELO DOMINICK PRESIDENT AND CEO

2020-05-08 M 13,125 $2.75 a 210,492 210,492.00 direct

HAGEN HEIDI

2020-04-29 M 1,750 a 1,750 1,750.00 direct

GILMAN STEVEN C

2020-04-29 A 1,750 a 1,750 1,750.00 direct

GILMAN STEVEN C

2020-04-29 M 1,750 a 1,750 1,750.00 direct

WOTTON PAUL K

2020-04-29 M 1,750 $14.56 d 0 1,750.00 direct

ZERBE ROBERT L MD

2020-04-29 A 1,750 a 1,750 19,295.00 direct

RUBINO ALAN L

2020-04-29 A 13,125 a 13,125 2,684.00 direct

RUBINO ALAN L

2020-04-29 M 1,750 a 2,644 2,684.00 direct

MCLAUGHLIN KEVIN F

2020-04-29 M 1,750 $14.56 d 0 1,750.00 direct

HAGEN HEIDI

2020-04-29 A 1,750 a 1,750 1,750.00 direct

GILMAN STEVEN C

2020-04-29 A 13,125 a 13,125 1,750.00 direct

WOTTON PAUL K

2020-04-29 A 1,750 a 1,750 1,750.00 direct

WOTTON PAUL K

2020-04-29 M 1,750 a 1,750 1,750.00 direct

ZERBE ROBERT L MD

2020-04-29 M 1,750 d 0 19,295.00 direct

RUBINO ALAN L

2020-04-29 A 1,750 a 1,750 2,684.00 direct

MCLAUGHLIN KEVIN F

2020-04-29 A 1,750 a 1,750 1,750.00 direct

MCLAUGHLIN KEVIN F

2020-04-29 M 1,750 a 1,750 1,750.00 direct

HAGEN HEIDI

2020-04-29 M 1,750 $14.56 d 0 1,750.00 direct

GILMAN STEVEN C

2020-04-29 M 1,750 $14.56 d 0 1,750.00 direct

WOTTON PAUL K

2020-04-29 A 13,125 a 13,125 1,750.00 direct

ZERBE ROBERT L MD

2020-04-29 A 13,125 a 13,125 19,295.00 direct

ZERBE ROBERT L MD

2020-04-29 M 1,750 a 19,295 19,295.00 direct

RUBINO ALAN L

2020-04-29 M 1,750 $14.56 d 0 2,684.00 direct

MCLAUGHLIN KEVIN F

2020-04-29 A 13,125 a 13,125 1,750.00 direct

HAGEN HEIDI

2020-04-29 A 13,125 a 13,125 1,750.00 direct

Elevate your investments